Kanerva J - Search Results

1

STRN-ALK rearranged pediatric malignant peritoneal mesothelioma - Functional testing of 527 cancer drugs in patient-derived cancer cells.

Murumägi A, Ungureanu D, Arjama M, Bützow R, Lohi J, Sariola H, Kanerva J, Koskenvuo M, Kallioniemi O. Murumägi A, et al. Among authors: kanerva j. Transl Oncol. 2021 Apr;14(4):101027. doi: 10.1016/j.tranon.2021.101027. Epub 2021 Jan 30. Transl Oncol. 2021. PMID: 33530027 Free PMC article.

2

DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.

Nielsen SN, Grell K, Nersting J, Abrahamsson J, Lund B, Kanerva J, Jónsson ÓG, Vaitkeviciene G, Pruunsild K, Hjalgrim LL, Schmiegelow K. Nielsen SN, et al. Among authors: kanerva j. Lancet Oncol. 2017 Apr;18(4):515-524. doi: 10.1016/S1470-2045(17)30154-7. Epub 2017 Mar 1. Lancet Oncol. 2017. PMID: 28258828 Clinical Trial.

3

Multimodal classification of molecular subtypes in pediatric acute lymphoblastic leukemia.

Krali O, Marincevic-Zuniga Y, Arvidsson G, Enblad AP, Lundmark A, Sayyab S, Zachariadis V, Heinäniemi M, Suhonen J, Oksa L, Vepsäläinen K, Öfverholm I, Barbany G, Nordgren A, Lilljebjörn H, Fioretos T, Madsen HO, Marquart HV, Flaegstad T, Forestier E, Jónsson ÓG, Kanerva J, Lohi O, Norén-Nyström U, Schmiegelow K, Harila A, Heyman M, Lönnerholm G, Syvänen AC, Nordlund J. Krali O, et al. Among authors: kanerva j. NPJ Precis Oncol. 2023 Dec 8;7(1):131. doi: 10.1038/s41698-023-00479-5. NPJ Precis Oncol. 2023. PMID: 38066241 Free PMC article.

4

Loss at 12p detected by comparative genomic hybridization (CGH): association with TEL-AML1 fusion and favorable prognostic features in childhood acute lymphoblastic leukemia (ALL). A multi-institutional study.

Kanerva J, Niini T, Vettenranta K, Riikonen P, Mäkipernaa A, Karhu R, Knuutila S, Saarinen-Pihkala UM. Kanerva J, et al. Med Pediatr Oncol. 2001 Nov;37(5):419-25. doi: 10.1002/mpo.1224. Med Pediatr Oncol. 2001. PMID: 11745869

5

Physical performance of nontransplanted childhood ALL survivors is comparable to healthy controls.

Taskinen MH, Kurimo M, Kanerva J, Hovi L. Taskinen MH, et al. Among authors: kanerva j. J Pediatr Hematol Oncol. 2013 May;35(4):276-80. doi: 10.1097/MPH.0b013e3182830ffa. J Pediatr Hematol Oncol. 2013. PMID: 23459381

6

DNA methylation-based subtype prediction for pediatric acute lymphoblastic leukemia.

Nordlund J, Bäcklin CL, Zachariadis V, Cavelier L, Dahlberg J, Öfverholm I, Barbany G, Nordgren A, Övernäs E, Abrahamsson J, Flaegstad T, Heyman MM, Jónsson ÓG, Kanerva J, Larsson R, Palle J, Schmiegelow K, Gustafsson MG, Lönnerholm G, Forestier E, Syvänen AC. Nordlund J, et al. Among authors: kanerva j. Clin Epigenetics. 2015 Feb 17;7(1):11. doi: 10.1186/s13148-014-0039-z. eCollection 2015. Clin Epigenetics. 2015. PMID: 25729447 Free PMC article.

7

Heart Transplantation for Early-Onset Anthracycline-Induced Cardiomyopathy Within 5 Months of Chemotherapy Completion.

Kaskinen AK, Helle E, Pihkala J, Jahnukainen T, Kanerva J, Mäyränpää MI, Lemström K, Mattila I, Ojala T. Kaskinen AK, et al. Among authors: kanerva j. JACC Case Rep. 2021 Nov 3;3(15):1677-1679. doi: 10.1016/j.jaccas.2021.07.004. eCollection 2021 Nov 3. JACC Case Rep. 2021. PMID: 34766017 Free PMC article.

8

Reemphasis on lymphoblast L2 morphology as a poor prognostic factor in childhood acute lymphoblastic leukemia.

Kanerva J, Saarinen-Pihkala UM, Riikonen P, Mäkipernaa A, Möttönen M, Salmi TT. Kanerva J, et al. Med Pediatr Oncol. 1999 Oct;33(4):388-94. doi: 10.1002/(sici)1096-911x(199910)33:4<388::aid-mpo8>3.0.co;2-n. Med Pediatr Oncol. 1999. PMID: 10491548

9

Multiple drug resistance mediated by P-glycoprotein is not a major factor in a slow response to therapy in childhood ALL.

Kanerva J, Tiirikainen M, Mäkipernaa A, Riikonen P, Möttönen M, Salmi TT, Krusius T, Saarinen-Pihkala UM. Kanerva J, et al. Pediatr Hematol Oncol. 1998 Jan-Feb;15(1):11-21. doi: 10.3109/08880019809009504. Pediatr Hematol Oncol. 1998. PMID: 9509502

10

Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-up.

Kanerva J, Tiirikainen MI, Mäkipernaa A, Riikonen P, Möttönen M, Salmi TT, Krusius T, Saarinen-Pihkala UM. Kanerva J, et al. Pediatr Hematol Oncol. 2001 Jan-Feb;18(1):27-36. doi: 10.1080/088800101750059837. Pediatr Hematol Oncol. 2001. PMID: 11205837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters